Global Virus Purification Kits Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Virus Type;

Adenovirus, Lentivirus, Retrovirus and Others.

By End User;

Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn903751766 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Virus Purification Kits Market (USD Million), 2021 - 2031

In the year 2024, the Global Virus Purification Kits Market was valued at USD 1,853.56 million. The size of this market is expected to increase to USD 3,848.30 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.0%.

The global virus purification kits market stands at the forefront of combating infectious diseases and advancing biomedical research. These kits serve as essential tools in isolating and purifying viruses from various biological samples, facilitating diagnostic procedures, vaccine development, and fundamental virological studies. With the ongoing threat of emerging viral pathogens and the need for robust research tools, the market for virus purification kits has witnessed significant growth in recent years.

Driven by technological advancements and increasing investments in life sciences research, the market offers a diverse range of purification kits tailored to different viruses and sample types. From traditional methods to innovative techniques utilizing chromatography, filtration, and ultracentrifugation, manufacturers continually strive to enhance kit performance, efficiency, and ease of use. Moreover, the COVID-19 pandemic has underscored the importance of rapid and reliable virus purification methods, further propelling market expansion and innovation efforts. As researchers and healthcare professionals worldwide continue to address existing and emerging viral threats, the demand for advanced virus purification kits is expected to remain robust, driving continued market growth and evolution.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Virus Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Virus Purification Kits Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological Advancements
        2. Increasing Demand for Biopharmaceuticals
        3. Rising Prevalence of Infectious Diseases
      2. Restraints
        1. Stringent Regulatory Requirements
        2. High Cost of Purification Kits
        3. Limited Awareness in Developing Regions
      3. Opportunities
        1. Expansion of Healthcare Infrastructure
        2. Growing Research and Development Activities
        3. Emergence of Novel Viral Diseases
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Global Virus Purification Kits Market, By Virus Type, 2021 - 2031 (USD Million)
      1. Adenovirus
      2. Lentivirus
      3. Retrovirus
      4. Others
    2. Global Virus Purification Kits Market, By End User, 2021 - 2031 (USD Million)
      1. Academic & Research Institutes
      2. Biopharmaceutical & Biotechnology Companies
      3. Contract Research Organizations (CROs)
      4. Others
    3. Global Virus Purification Kits Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Merck KGaA
      2. Danaher Corporation
      3. Thermo Fisher Scientific, Inc.
      4. Sartorius AG
      5. Lonza Group Ltd.
      6. Asahi Kasei Corporation
      7. BioVision Inc.
      8. PendoTECH
      9. QIAGEN
      10. Takara Bio Inc
  7. Analyst Views
  8. Future Outlook of the Market